Critical illness is associated with a marked increase in metabolic rate and
progressive wasting, despite aggressive nutritional support. The metabolic
events which are responsible for these phenomena are unclear, but are char
acterised by marked impairment of the anabolic effects of insulin on glucos
e metabolism and excessive activation of the sympathetic nervous system. It
has been suggested that critical illness may be associated with impaired c
arbohydrate oxidation and a marked increase in the loss of heat energy asso
ciated with glucose administration (glucose-induced thermogenesis). This si
tuation may result in impaired efficiency of nutrient assimilation. Studies
employing combinations of nutrient infusions both at clinically-relevant r
ates and in association with euglycaemic hyperinsulinaemia have, however, d
emonstrated that nutrient-induced thermogenesis is unaffected in critical i
llness in human subjects, and that defective glucose utilization occurs as
a consequence of impaired insulin-mediated glucose storage rather than oxid
ation. Although the cellular and molecular mechanisms underlying these chan
ges are controversial, the recent validation of a human model of insulin re
sistance in critical illness should provide a means of studying this respon
se in future, and allow the identification of therapeutic targets. This inf
ormation should increase the efficacy of nutritional support in some of our
most seriously-ill patients.